Prasinezumab | m-entrepreneurship.com

Product Name :
Prasinezumab

Search keywords :
Prasinezumab

drugId :
null

Target Vo:
Synuclein alpha

Target Vo Short Name :
SNCA

Moa_Name:
Synuclein alpha inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Prothena

Active Company_Name :
F. Hoffmann-La Roche Ag

Active Indication_Name:
Parkinson Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NF-KB p65 Rabbit mAb In Vitro
PARP1 Rabbit mAb Biological Activity
PKC beta 2 Antibody: PKC beta 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to PKC beta 2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts